Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1506 of 6351
-
Could 'Good' bacteria on your skin tame psoriasis? new trial aims to find out
Disease control Recruiting nowA growing body of evidence indicates that the pathogenesis of psoriasis may be closely linked to skin microbiome dysbiosis. Compared with healthy individuals, the composition and function of the skin microbiota in psoriasis patients exhibit significant alterations5,6. This microb…
Phase 2 • Sponsor: Shenzhen People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a little liver radiation boost cancer immunotherapy?
Disease control Recruiting nowThe purpose of this study is to see if adding Low-Dose Liver Radiation (LD-LRT) improves progression free survival (PFS). This study is for patients with either melanoma or non-small cell lung cancer (NSCLC), with liver metastases, and receiving immunotherapy.
Sponsor: Jordan Kharofa • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Painless mouth scans could replace biopsies for oral cancer detection
Diagnosis Recruiting nowCancers of the oral cavity (lip, oral tongue, gingivae, floor of mouth, hard palate, and other mouth tissues including buccal mucosa) are amongst the most common worldwide, with an estimated annual burden of over 300,000 incident cases. Most oral cancers (\>75%) are attributable …
Sponsor: Anil Chaturvedi • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New shingles pain pill shows promise in major trial
Symptom relief Recruiting nowHerpes zoster (HZ) is characterized by a painful dermatomal rash and significantly affects quality of life, with acute pain increasing the risk of postherpetic neuralgia. Although early antiviral therapy limits viral replication, its analgesic effect is insufficient, and many pat…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New 5-Day TMS treatment could rapidly ease PTSD symptoms
Symptom relief Recruiting nowPost-traumatic stress disorder (PTSD) is a highly prevalent and debilitating condition among veterans and active-duty military personnel, with rates as high as 30% in certain combat-exposed populations. Conventional treatments such as prolonged exposure therapy and pharmacotherap…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Not yet recruitingThe purpose of this clinical trial is to learn if autologous claudin18.2-directed chimeric antigen receptor T-cell (CAR-T) therapy works to treat claudin18.2 positive solid tumors in adults. It will also learn about the safety and efficacy of the autologous claudin18.2 CAR-T cell…
Early phase 1 • Sponsor: Chengdu Ucello Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a fun group workout ease anxiety and depression in kids and teens?
Symptom relief By invitation onlyThe Confident, Active, and Happy Youth (CAHY) project aims to address the significant functional impairments experienced by youths with symptoms of depression and anxiety, focusing on physical activity (PA) and social participation. Traditional treatments, such as psychotherapy a…
Sponsor: Haukeland University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Precision brain zapping: new hope for stubborn depression?
Symptom relief Not yet recruitingStudy comparing standard repetitive transcranial magnetic stimulation (rTMS) for Depression to a novel targeting approach using brain surface parcellation to locate a specific brain target.
Phase 2 • Sponsor: Soterix Medical • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can oxygen chambers boost heart failure treatment?
Disease control Not yet recruitingThis study aims to investigate whether adjunctive hyperbaric oxygen therapy, compared to guideline-directed medical therapy with the "New Four Pillars" (ARNI/ACEI/ARB + β-blocker + MRA + SGLT2 inhibitor) alone, improves cardiac function in patients with chronic heart failure, and…
Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a 14-Day pill reverse stomach precancer?
Disease control Recruiting nowThis study is designed to test the use of Pyrvinium vs placebo as a treatment for gastric intestinal metaplasia with features associated with increased risk of cancer. Response will be determined by assessing the extent and quality of the gastric intestinal metaplasia before and …
Phase 2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug combo targets fatty liver in major trial
Disease control Recruiting nowThe primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fractio…
Phase 2 • Sponsor: Eccogene • Aim: Disease control
Last updated Sep 10, 2026 09:00 UTC
-
Video game therapy shows promise for kids with cerebral palsy
Symptom relief Not yet recruitingCerebral Palsy (CP) accounts for approximately 0.9% of the global disease burden and affects 2.4-4% of children under 5 years old, with associated developmental and coordination impairments. Pediatric physical therapy aims to enhance independence and quality of life; however, mai…
Sponsor: Ziauddin University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could a shot of your own cells boost fertility? new trial aims to find out.
Disease control Not yet recruitingPoor ovarian response (POR) is a pathological state where the ovaries do not respond well to the stimulation of gonadotropins. It is mainly characterized by a small number of developing follicles, a high cancellation rate of the ovarian stimulation cycle, a low number of retrieve…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New 'Spot Delete' proton therapy aims to spare prostate cancer patients from bowel troubles
Symptom relief Recruiting nowThis purpose of this study is to examine the placement of proton spots during pencil beam scanning proton therapy for low and intermediate risk prostate cancer. The researchers will test a unique technique called "Spot Delete" to control the placement of spots during treatment pl…
Sponsor: Covenant Health Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is to evaluate the efficacy and safety of the LM-24C5 in combination with other therapies in subjects with CEACAM5-positive advanced solid tumor
Phase 2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New immunotherapy combo targets High-Risk prostate cancer before and after surgery
Disease control CancelledThis Phase 2 clinical trial is testing a new immunotherapy combination (N-803, ETBX-071, M-CENK) for men with high-risk prostate cancer before and after prostate surgery. The goal is to see if this treatment improves cancer outcomes and is safe.
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could fear of movement slow spine surgery recovery?
Knowledge-focused CompletedLumbar disc herniation is a common condition that may impair physical functioning and reduce independence in activities of daily living. Although surgery aims to relieve symptoms and improve functional recovery, individual factors present before surgery may influence postoperativ…
Sponsor: Aydin Adnan Menderes University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New immune cell therapy targets Hard-to-Treat cancers
Disease control OngoingAn open label, dose-escalation clinical study to evaluate the safety, anti-tumor activity and pharmacokinetics/pharmacodynamic (PK/PD) of NW-301VT in subjects with advanced solid tumor.
Phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Nepal tests community health workers to tackle dual epidemic of hypertension and diabetes
Disease control Recruiting nowHypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other …
Sponsor: Kathmandu University School of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could games and peer support transform orphan dental care?
Prevention CompletedBackground: Orphan children are at higher risk of developing oral diseases, compared to non-orphans. They also face various emotional, social, and psychological distresses which affect their general as well as oral health. Aim: To evaluate the effectiveness of three methods of de…
Sponsor: Alexandria University • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC